Author

Magdolna Kovács

Observed names: Kovács, Magdolna, M Kovacs, M Kovács, M. Kovacs, M. Kovács, MAGDOLNA KOVACS, Magdolna Kovacs, Magdolna Kovàcs

Institutions: University of Miami, Veterans Health Administration, South Florida Veterans Affairs Foundation for Research and Education, Miami VA Healthcare System

Observed institutions: Semmelweis University, Tulane University, United States Department of Veterans Affairs, University of Nottingham, University of Miami, Veterans Health Administration, National Institute of Oncology, South Florida Veterans Affairs Foundation for Research and Education, Miami VA Healthcare System, Hungarian Academy of Sciences, University of Pecs

OpenAlex ID: A5009216612

Hypothalamic Hormones and Cancer

2001 · Andrew V. Schally, Ana Maria Comaru-Schally, et al. · Frontiers in Neuroendocrinology · 254

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

1996 · A Nagy, A V Schally, et al. · Proceedings of the National Academy of Sciences · 204

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin

1998 · Attila Nagy, Andrew V. Schally, et al. · Proceedings of the National Academy of Sciences · 145

Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects.

1988 · S Bajusz, M Kovacs, et al. · Proceedings of the National Academy of Sciences · 87

Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities

2013 · Renzhi Cai, Andrew V. Schally, et al. · Peptides · 85

Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth

2017 · Marta Zarandi, Renzhi Cai, et al. · Peptides · 59

Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone

1997 · Magdolna Kovacs, Andrew V. Schally, et al. · Proceedings of the National Academy of Sciences · 57

Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH

2001 · Magdolna Kovacs, Andrew V. Schally, et al. · Proceedings of the National Academy of Sciences · 51

Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10

2004 · Jozsef L. Varga, Andrew V. Schally, et al. · Proceedings of the National Academy of Sciences · 50

Lamprey Gonadotropin Hormone‐Releasing Hormone‐III has No Selective Follicle‐Stimulating Hormone‐Releasing Effect In Rats

2002 · M. Kovacs, J. Seprodi, et al. · Journal of Neuroendocrinology · 49

PDF

New Derivatives of GnRH as Potential Anticancer Therapeutic Agents

2008 · Gabor Mezo, Marilena Manea, et al. · Current Medicinal Chemistry · 48

Direct anticancer activity of gonadotropin‐releasing hormone‐III

1998 · S. Lovas, I. Páyi, et al. · Journal of Peptide Research · 48

Synthesis and In Vitro Evaluation of New Potent Antagonists of Growth Hormone-Releasing Hormone (GH-RH)

1997 · Marta Zarandi, Magdolna Kovacs, et al. · Peptides · 48

Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) on GH and Insulin-Like Growth Factor I Levels in Transgenic Mice Overexpressing the Human GHRH Gene, an Animal Model of Acromegaly

1997 · Magdolna Kovacs, Rhonda D. Kineman, et al. · Endocrinology · 44

Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats

2002 · Judit E. Horvath, Ana M. Bajo, et al. · Proceedings of the National Academy of Sciences · 42

Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats

2001 · Magdolna Kovacs, Andrew V. Schally · Proceedings of the National Academy of Sciences · 37

PDF

Combining Growth Hormone-Releasing Hormone Antagonist With Luteinizing Hormone-Releasing Hormone Antagonist Greatly Augments Benign Prostatic Hyperplasia Shrinkage

2012 · Ferenc G. Rick, Luca Szalontay, et al. · The Journal of Urology · 35

Structure–activity study on the LH- and FSH-releasing and anticancer effects of gonadotropin-releasing hormone (GnRH)-III analogs

2007 · Magdolna Kovács, Borbála Vincze, et al. · Peptides · 33

Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action

1996 · M Kovacs, M Zarándi, et al. · Endocrinology · 33

PDF

Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives

2007 · Gábor Mező, András Czajlik, et al. · Peptides · 27

A correlation of endocrine and anticancer effects of some antagonists of GHRH

2010 · Magdolna Kovács, Andrew V. Schally, et al. · Peptides · 25

Synthesis, Conformation, Biodistribution, and Hormone-Related in Vitro Antitumor Activity of a Gonadotropin-Releasing Hormone Antagonist−Branched Polypeptide Conjugate

1996 · Gábor Mezö, Imre Mezö, et al. · Bioconjugate Chemistry · 24

Endocrine and Antineoplastic Actions of Growth Hormone-Releasing Hormone Antagonists

2008 · Magdolna Kovacs, Andrew Schally, et al. · Current Medicinal Chemistry · 23

Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities

2006 · Marta Zarandi, Jozsef L. Varga, et al. · Proceedings of the National Academy of Sciences · 22

Inhibition of GH Release in Rats by New Potent Antagonists of Growth Hormone-Releasing Hormone (GH-RH)

1997 · Magdolna Kovács, Andrew V. Schally, et al. · Peptides · 20

Works count: 59

Citation count: 1,762

H-index: 23

I10-index: 36